Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

MAGEA8 antibody (AA 1-270) (FITC)

The Rabbit Polyclonal anti-MAGEA8 antibody has been validated for . It is suitable to detect MAGEA8 in samples from Human.
Catalog No. ABIN7159275

Quick Overview for MAGEA8 antibody (AA 1-270) (FITC) (ABIN7159275)

Target

See all MAGEA8 Antibodies
MAGEA8 (Melanoma Antigen Family A, 8 (MAGEA8))

Reactivity

  • 18
  • 1
Human

Host

  • 17
  • 1
Rabbit

Clonality

  • 17
  • 1
Polyclonal

Conjugate

  • 9
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
This MAGEA8 antibody is conjugated to FITC

Application

Please inquire
  • Binding Specificity

    • 4
    • 3
    • 1
    • 1
    • 1
    • 1
    AA 1-270

    Cross-Reactivity

    Human

    Purification

    >95%, Protein G purified

    Immunogen

    Recombinant Human Melanoma-associated antigen 8 protein (1-270AA)

    Isotype

    IgG
  • Restrictions

    For Research Use only
  • Format

    Liquid

    Buffer

    Preservative: 0.03 % Proclin 300
    Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4

    Preservative

    ProClin

    Precaution of Use

    This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Storage

    -20 °C,-80 °C

    Storage Comment

    Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
  • Target

    MAGEA8 (Melanoma Antigen Family A, 8 (MAGEA8))

    Alternative Name

    MAGEA8

    Background

    Background: Not known, though may play a role in embryonal development and tumor transformation or aspects of tumor progression.

    Aliases: Cancer/testis antigen 1.8 antibody, cancer/testis antigen family 1, member 8 antibody, CT1.8 antibody, MAGA8_HUMAN antibody, MAGE 8 antigen antibody, MAGE-8 antigen antibody, MAGE8 antigen antibody, MAGEA8 antibody, Melanoma antigen family A 8 antibody, Melanoma associated antigen 8 antibody, Melanoma-associated antigen 8 antibody, MGC2182 antibody

    UniProt

    P43361
You are here:
Chat with us!